Article révisé par les pairs
Titre:
  • Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial.
Auteur:Leboulleux, Sophie; Bastholt, Lars; Krause, Thomas; de la Fouchardiere, Christelle; Tennvall, Jan; Awada, Ahmad; Gómez, José Manuel; Bonichon, F.; Leenhardt, Laurence; Soufflet, Christine; Licour, Muriel; Schlumberger, Martin Jean
Informations sur la publication:Lancet oncology, 13, 9, page (897-905)
Statut de publication:Publié, 2012-09
Sujet CREF:Cancérologie
MeSH keywords:Adenocarcinoma, Follicular
Adolescent
Adult
Aged
Antineoplastic Agents -- therapeutic use
Bone Neoplasms -- secondary
Carcinoma
Diarrhea -- chemically induced
Disease-Free Survival
Double-Blind Method
Electrocardiography -- drug effects
Female
Heart Conduction System -- drug effects
Humans
Kaplan-Meier Estimate
Lung Neoplasms -- secondary
Lymphatic Metastasis
Male
Middle Aged
Piperidines -- adverse effects -- therapeutic use
Quinazolines -- adverse effects -- therapeutic use
Receptor, Epidermal Growth Factor -- antagonists & inhibitors
Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors
Skin Neoplasms -- secondary
Survival Analysis
Thyroid Neoplasms -- drug therapy -- mortality -- pathology -- secondary
Young Adult
Note générale:Clinical Trial, Phase II
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1470-2045
info:doi/10.1016/S1470-2045(12)70335-2
info:pii/S1470-2045(12)70335-2
info:scp/84865552505
info:pmid/22898678

Documents en relation

DI-fusion